| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/15/2001 | US6232097 Nucleotide sequences coding enzymatic polypeptide; prevent bacterial infection; wound healing agents; for vaccine development |
| 05/15/2001 | US6232096 Flea serine protease nucleic acid molecules and uses thereof |
| 05/15/2001 | US6232094 DNA encoding human κ casein and process for obtaining the protein |
| 05/15/2001 | US6232077 Genetic engineering and expression; cancer diagnosis |
| 05/15/2001 | US6232064 Fibrosis and atherosclerosis determination |
| 05/15/2001 | US6231881 Medium and matrix for long-term proliferation of cells |
| 05/15/2001 | US6231879 Implantable, biocompatible cell encapsulation with jackets |
| 05/15/2001 | US6231863 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 05/15/2001 | US6231854 Methioninase formulations and use in diagnostic methods |
| 05/15/2001 | US6231852 Method for reducing BCL-2 expressing cells resistance to death |
| 05/15/2001 | US6231605 Frozen and thawed in mold to create interlocking mesh; expanded and immersed in water solution; human tissue replacement; biocompatibility |
| 05/15/2001 | CA2083948C Glyphosate tolerant plants |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341229C Procoagulant proteins derived from factor viii: c |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001033199A2 Universal fluorescent sensors |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032926A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032901A1 Expression vectors, transfection systems, and method of use thereof |
| 05/10/2001 | WO2001032900A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 05/10/2001 | WO2001032898A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 05/10/2001 | WO2001032888A2 Human transferase molecules |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |
| 05/10/2001 | WO2001032878A2 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | WO2001032876A2 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | WO2001032867A1 Polypeptides with expanded primary signalling motifs |
| 05/10/2001 | WO2001032866A2 Hybrid adaptor receptors |
| 05/10/2001 | WO2001032865A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | WO2001032864A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | WO2001032843A2 Enhanced immune recognition of pathogenic cells by icsbp expression |
| 05/10/2001 | WO2001032842A1 ηc NEGATIVE HEMATOPOIETIC PROGENITOR CELLS |
| 05/10/2001 | WO2001032841A2 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 05/10/2001 | WO2001032840A2 Hair transplantation |
| 05/10/2001 | WO2001032839A2 Medium for preparing dedifferentiated cells |
| 05/10/2001 | WO2001032838A2 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 05/10/2001 | WO2001032837A1 19 human secreted proteins |
| 05/10/2001 | WO2001032710A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | WO2001032709A2 Polypeptides with non-natural primary signalling motifs |
| 05/10/2001 | WO2001032704A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | WO2001032703A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | WO2001032702A2 Molecular structure of rhd negative locus |
| 05/10/2001 | WO2001032696A2 Traf family proteins |
| 05/10/2001 | WO2001032687A1 10 human secreted proteins |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032677A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | WO2001032676A1 25 human secreted proteins |
| 05/10/2001 | WO2001032675A1 32 human secreted proteins |
| 05/10/2001 | WO2001032674A1 26 human secreted proteins |
| 05/10/2001 | WO2001032673A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | WO2001032614A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | WO2001032189A1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 05/10/2001 | WO2001032129A2 Augmentation and repair of age-related soft tissue defects |
| 05/10/2001 | WO2001032128A2 Human chemokine beta-13 |
| 05/10/2001 | WO2001032126A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | WO2001032015A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 05/10/2001 | WO2001032009A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | WO2001021804B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/10/2001 | WO2001021766A8 Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells |
| 05/10/2001 | WO2001019379A3 Methods for treating muscular dystrophy with bone marrow cells |
| 05/10/2001 | WO2001016304A3 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/10/2001 | WO2001011011A3 Multipotent adult stem cells and methods for isolation |
| 05/10/2001 | WO2001006949A3 In vitro repair of bone and/or cartilage defects |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072885A3 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000064488A3 Somatic transgene immunization and related methods |
| 05/10/2001 | WO2000063435A8 Method of identifying toxic agents using differential gene expression |
| 05/10/2001 | WO2000063241A3 Methods and compositions for modulating an immune response |
| 05/10/2001 | WO2000060059A3 Alpha-amylase variants |
| 05/10/2001 | WO2000047720A3 Pancreatic progenitor cells, methods and uses related thereto |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | US20010001066 Method for stimulating an immune response |
| 05/10/2001 | US20010001039 Wound healing agents, especially for chronic wounds, e.g., diabetic wounds, ulcers, using keratinocytes grown on a transplantable solid support, e.g. collagen-coated beads; enclosure of mesh housing the support and placed in the wound |
| 05/10/2001 | CA2390180A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 05/10/2001 | CA2390053A1 Augmentation and repair of age-related soft tissue defects |
| 05/10/2001 | CA2389852A1 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | CA2389754A1 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 05/10/2001 | CA2389751A1 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 05/10/2001 | CA2389676A1 Substance capable of controlling the inclusion of exon 10 of the tau gene, and its therapeutic use against tauopathies |
| 05/10/2001 | CA2389672A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 05/10/2001 | CA2389646A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | CA2389644A1 A novel polypeptide hormone phosphatonin |
| 05/10/2001 | CA2389633A1 Expression vectors, transfection systems, and method of use thereof |
| 05/10/2001 | CA2389415A1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 05/10/2001 | CA2389335A1 Gene expression directed by a super-psa promoter |
| 05/10/2001 | CA2389329A1 Dog and rabbit motilin receptor orthologs |
| 05/10/2001 | CA2389057A1 Methods for improving viral vector titers and reducing cell death in cell cultures |
| 05/10/2001 | CA2388822A1 27 human secreted proteins |
| 05/10/2001 | CA2388612A1 Sequences encoding human neoplastic marker |
| 05/10/2001 | CA2388511A1 Tissue specific genes of diagnostic import |
| 05/10/2001 | CA2388510A1 Use of haploid genomes for genetic diagnosis, modification and multiplication |
| 05/10/2001 | CA2388308A1 Gpcr-kd5 polypeptides and dna sequences thereof |
| 05/10/2001 | CA2388208A1 Medium for preparing dedifferentiated cells |
| 05/10/2001 | CA2387808A1 Human chemokine beta-13 |
| 05/10/2001 | CA2387801A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 05/10/2001 | CA2387799A1 19 human secreted proteins |
| 05/10/2001 | CA2387785A1 Human transferase molecules |